For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
The price of Phathom Pharmaceuticals Inc (NASDAQ: PHAT) closed at $4.88 in the last session, up 18.73% from day before closing price of $4.11. In other words, the price has increased by $18.73 from its previous closing price. On the day, 1.26 million shares were traded. PHAT stock price reached its highest trading level at $4.94 during the session, while it also had its lowest trading level at $4.05.
Ratios:
We take a closer look at PHAT’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 4.16 and its Current Ratio is at 4.20.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Cantor Fitzgerald on February 14, 2025, initiated with a Overweight rating and assigned the stock a target price of $23.
On May 03, 2024, Stifel started tracking the stock assigning a Buy rating and target price of $24.
Needham reiterated its Buy rating for the stock on January 05, 2024, while the target price for the stock was revised from $23 to $26.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Apr 07 ’25 when Henderson Molly sold 3,678 shares for $4.55 per share. The transaction valued at 16,740 led to the insider holds 89,868 shares of the business.
Parikh Asit bought 10,000 shares of PHAT for $44,200 on Mar 13 ’25. The Director now owns 85,500 shares after completing the transaction at $4.42 per share. On Jan 21 ’25, another insider, Henderson Molly, who serves as the CFO and CBO of the company, sold 6,583 shares for $6.59 each. As a result, the insider received 43,371 and left with 93,546 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PHAT now has a Market Capitalization of 339828576 and an Enterprise Value of 597513344. For the stock, the TTM Price-to-Sale (P/S) ratio is 6.15. Its current Enterprise Value per Revenue stands at 10.814 whereas that against EBITDA is -2.16.
Stock Price History:
The Beta on a monthly basis for PHAT is 0.29, which has changed by -0.512974 over the last 52 weeks, in comparison to a change of 0.059571505 over the same period for the S&P500. Over the past 52 weeks, PHAT has reached a high of $19.71, while it has fallen to a 52-week low of $3.81. The 50-Day Moving Average of the stock is -11.44%, while the 200-Day Moving Average is calculated to be -54.08%.
Shares Statistics:
According to the various share statistics, PHAT traded on average about 1.21M shares per day over the past 3-months and 1501090 shares per day over the past 10 days. A total of 68.52M shares are outstanding, with a floating share count of 38.70M. Insiders hold about 44.53% of the company’s shares, while institutions hold 60.24% stake in the company. Shares short for PHAT as of 1743379200 were 12910348 with a Short Ratio of 10.68, compared to 1740700800 on 13923473. Therefore, it implies a Short% of Shares Outstanding of 12910348 and a Short% of Float of 25.97.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
